Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.

IF 5.1 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Heart Pub Date : 2025-04-16 DOI:10.1136/heartjnl-2024-325608
Christopher J Love, Joshua Lampert, David Huneycutt, Dan L Musat, Mahek Shah, Jorge E Silva Enciso, Bryan Doherty, James L Gentry, Michael D Kwan, Ethan C Carter, Vivek Y Reddy
{"title":"Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.","authors":"Christopher J Love, Joshua Lampert, David Huneycutt, Dan L Musat, Mahek Shah, Jorge E Silva Enciso, Bryan Doherty, James L Gentry, Michael D Kwan, Ethan C Carter, Vivek Y Reddy","doi":"10.1136/heartjnl-2024-325608","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic cardiomyopathy (HCM) is often underdiagnosed. Artificial intelligence (AI)-based notification of HCM suspicion on a 12-lead ECG has been proposed to assist patient identification and evaluation. However, there has been no study to date to assess clinical implementation of this approach.</p><p><strong>Methods: </strong>In an open-label, multicentre prospective cohort study, Viz HCM (Viz.ai)-an AI-ECG software alerting of suspected HCM-was implemented at five healthcare systems between January and December 2023 to identify patients >18 years of age without prior HCM diagnosis. The coprimary endpoints were the percentage of HCM-suspected cases viewed by users and the types of follow-up actions. Additional outcome measures included the time to follow-up, demographic characteristics of enrolled patients and follow-up outcomes.</p><p><strong>Results: </strong>Out of 145 848 patients screened with algorithm-compliant ECGs, 4348 (3%) were alerted for suspected HCM. Users viewed 69% (3017/4348) of AI-suspected HCM cases. 217 patients met the study criteria and were enrolled with broad representation across racial and ethnic groups-including 23% Black, 9% Asian and 12% Hispanic or Latino. Of the enrolled patients, 182 (84%) had an indication for a total of 243 follow-up actions. The median (interquartile) time from ECG to diagnostic imaging indicating HCM was 7.5 (1.0-37.2) days. From the 217 enrolled patients, 17 (7.8%) were newly diagnosed with HCM-8 inpatient and 9 outpatient. During the study, deployment of an optimised algorithm operating point helped reduce the alert percentage of algorithm-screened patients from 4.4% (2097/47868) to 2.3% (2251/97980), p<0.0001, with no difference in the enrolment rate by alerts reviewed.</p><p><strong>Conclusion: </strong>An AI-based ECG device for HCM can be implemented successfully in a variety of clinical workflows to help identify new patients with HCM. Future study is warranted to assess scalability and comparisons to standard of care.</p>","PeriodicalId":12835,"journal":{"name":"Heart","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/heartjnl-2024-325608","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hypertrophic cardiomyopathy (HCM) is often underdiagnosed. Artificial intelligence (AI)-based notification of HCM suspicion on a 12-lead ECG has been proposed to assist patient identification and evaluation. However, there has been no study to date to assess clinical implementation of this approach.

Methods: In an open-label, multicentre prospective cohort study, Viz HCM (Viz.ai)-an AI-ECG software alerting of suspected HCM-was implemented at five healthcare systems between January and December 2023 to identify patients >18 years of age without prior HCM diagnosis. The coprimary endpoints were the percentage of HCM-suspected cases viewed by users and the types of follow-up actions. Additional outcome measures included the time to follow-up, demographic characteristics of enrolled patients and follow-up outcomes.

Results: Out of 145 848 patients screened with algorithm-compliant ECGs, 4348 (3%) were alerted for suspected HCM. Users viewed 69% (3017/4348) of AI-suspected HCM cases. 217 patients met the study criteria and were enrolled with broad representation across racial and ethnic groups-including 23% Black, 9% Asian and 12% Hispanic or Latino. Of the enrolled patients, 182 (84%) had an indication for a total of 243 follow-up actions. The median (interquartile) time from ECG to diagnostic imaging indicating HCM was 7.5 (1.0-37.2) days. From the 217 enrolled patients, 17 (7.8%) were newly diagnosed with HCM-8 inpatient and 9 outpatient. During the study, deployment of an optimised algorithm operating point helped reduce the alert percentage of algorithm-screened patients from 4.4% (2097/47868) to 2.3% (2251/97980), p<0.0001, with no difference in the enrolment rate by alerts reviewed.

Conclusion: An AI-based ECG device for HCM can be implemented successfully in a variety of clinical workflows to help identify new patients with HCM. Future study is warranted to assess scalability and comparisons to standard of care.

用于肥厚性心肌病检测的人工智能心电图的临床实现。
背景:肥厚性心肌病(HCM)经常被误诊。提出了基于人工智能(AI)的12导联心电图HCM疑似通知,以协助患者识别和评估。然而,迄今为止还没有研究评估这种方法的临床应用。方法:在一项开放标签、多中心前瞻性队列研究中,Viz HCM (Viz.ai)——一种预警疑似HCM的AI-ECG软件——于2023年1月至12月在5个医疗保健系统中实施,以识别年龄在18岁至18岁之间没有HCM诊断的患者。主要终点是用户看到的疑似hcm病例的百分比和后续行动的类型。其他结果测量包括随访时间、入组患者的人口统计学特征和随访结果。结果:在145848例使用符合算法的心电图筛查的患者中,4348例(3%)被提示有疑似HCM。用户查看了69%(3017/4348)的人工智能疑似HCM病例。217名患者符合研究标准,并且在种族和民族群体中具有广泛的代表性-包括23%的黑人,9%的亚洲人和12%的西班牙裔或拉丁裔人。在纳入的患者中,182例(84%)有适应症,总共进行了243次随访。从心电图到诊断影像显示HCM的中位时间(四分位数间隔)为7.5(1.0-37.2)天。在217例入组患者中,17例(7.8%)为新诊断的HCM-8住院患者,9例为门诊患者。在研究中,优化算法操作点的部署有助于将算法筛选患者的报警百分比从4.4%(2097/47868)降低到2.3%(2251/97980)。结论:基于人工智能的HCM心电图设备可以在各种临床工作流程中成功实施,以帮助识别新的HCM患者。未来的研究需要评估可扩展性和与标准护理的比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart
Heart 医学-心血管系统
CiteScore
10.30
自引率
5.30%
发文量
320
审稿时长
3-6 weeks
期刊介绍: Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access options available to authors for all articles. Education in Heart articles provide a comprehensive, continuously updated, cardiology curriculum.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信